TAKAO MASAKI

Last Updated :2025/05/09

Affiliations, Positions
Hiroshima University Hospital, Professor
E-mail
masakithiroshima-u.ac.jp
Self-introduction
My speciality is Nephrology.

Basic Information

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Kidney internal medicine

Affiliated Academic Societies

  • The Japanese Society of Internal Medicine Japanese Society of Nephrology The Japanese Society for Dialysis Therapy The Japanese Association of Rehabilitation Medicine Japanese Society for Peritoneal Dialysis Japanese Society for Hemodiafiltration American Society of Nephrology International Society of Nephrology European Renal Association

Educational Activity

Course in Charge

  1. 2025, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2025, Undergraduate Education, Intensive, Practice for medical research
  3. 2025, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2025, Undergraduate Education, Intensive, Practice of Medicine II
  5. 2025, Graduate Education (Master's Program) , 1Term, Advanced Lecture on Preventive Medicine for Evidence-based Health Guidance A
  6. 2025, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Nephrology
  7. 2025, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Nephrology
  8. 2025, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Nephrology
  9. 2025, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Nephrology

Research Activities

Academic Papers

  1. Early arteriovenous fistula failure associated with mortality and major adverse cardiovascular events in patients undergoing incident hemodialysis., J Vasc Access., 202312
  2. THE APOPROTEIN E (APOE) POLYMORPHISM AND PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) IN HEMODIALYSIS (HD) PATIENTS, Nephrology Dialysis Transplantation, 38((1)), 202306
  3. Mesenchymal stem cells pretreated with interferon-gamma attenuate renal fibrosis by enhancing regulatory T cell induction, SCIENTIFIC REPORTS, 14(1), 20240504
  4. Comparison of the pre-dilution and post-dilution methods for online hemodiafiltration, JOURNAL OF ARTIFICIAL ORGANS, 27(1), 48-56, 202403
  5. Encapsulating Peritoneal Sclerosis 43 Years after Distal Gastrectomy for Early Gastric Cancer, INTERNAL MEDICINE, 63(5), 659-663, 2024
  6. Adipose-derived mesenchymal stem cells cultured in serum-free medium attenuate acute contrast-induced nephropathy by exerting anti-apoptotic effects, STEM CELL RESEARCH & THERAPY, 14(1), 20231122
  7. Comparison of the Therapeutic Effects of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells on Renal Fibrosis, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(23), 202312
  8. Efficacy of polymethylmethacrylate membrane hemodiafilter Filtryzer((R)) PMFTM-21A in improving pruritus in hemodialysis patients: a prospective interventional study, RENAL REPLACEMENT THERAPY, 9(1), 20230804
  9. Cryoglobulinemic Vasculitis Associated with Monoclonal Gammopathy of Undetermined Significance Developed after Sustained Virologic Response of Hepatitis C, INTERNAL MEDICINE, 62(13), 1999-2004, 2023
  10. Nephrotic-range proteinuria and membranoproliferative glomerulonephritis-like pattern caused by interferon-beta 1b in a patient with multiple sclerosis, CEN CASE REPORTS, 12(3), 275-280, 202308
  11. Comparison of therapeutic effects of mesenchymal stem cells derived from superficial and deep subcutaneous adipose tissues, STEM CELL RESEARCH & THERAPY, 14(1), 20230504
  12. Cumulative Dialytic Glucose Exposure is a Risk Factor for Peritoneal Fibrosis and Angiogenesis in Pediatric Patients Undergoing Peritoneal Dialysis Using Neutral-pH Fluids, Kidney Int Rep, 7(11), 2431-2445, 20220903
  13. Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study, PLoS One, 17(11), 20221129
  14. Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients, Am J Nephrol ., 53(2-3), 169-175, 2022
  15. Klotho protects chromosomal DNA from radiation-induced damage, JOURNAL OF BIOCHEMISTRY, 173(5), 375-382, 20230426
  16. Comparison of survival rates between incident hemodialysis patients and peritoneal dialysis patients: a 5-year prospective cohort study with propensity score matching, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 27(5), 419-426, 202305
  17. alpha 1-and beta 2-Microglobulin reduction ratios and survival in patients on predilution online haemodiafiltration, NEPHROLOGY, 28(1), 44-50, 202301
  18. A case report of atypical anti-glomerular basement membrane disease, BMC NEPHROLOGY, 23(1), 20221119
  19. The hypoxia-inducible factor-alpha prolyl hydroxylase inhibitor FG4592 ameliorates renal fibrosis by inducing the H3K9 demethylase JMJD1A, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 323(5), F539-F552, 202211
  20. N-terminal pro-brain natriuretic peptide predicts hospitalization for ischemic stroke in Japanese hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 26(11), 1111-1118, 202211
  21. Relationships of hyperchloremia with hypertension and proteinuria in patients with chronic kidney disease, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 26(9), 880-885, 202209
  22. Penile calciphylaxis in patients with end-stage kidney disease undergoing dialysis: Invasive treatment and pain management, THERAPEUTIC APHERESIS AND DIALYSIS, 26(5), 950-959, 202210
  23. Coronary artery calcification is a risk factor for intradialytic hypotension in patients undergoing hemodialysis, HEMODIALYSIS INTERNATIONAL, 26(3), 335-344, 202207
  24. Upregulation of Mineralocorticoid Receptor Contributes to Development of Salt-Sensitive Hypertension after Ischemia-Reperfusion Injury in Rats, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(14), 7831-7831, 202207
  25. Synergistic Effects of the Geriatric Nutritional Risk Index and the Modified Creatinine Index for Predicting Mortality in Patients on Hemodialysis, NUTRIENTS, 14(12), 2398-2398, 202206
  26. Convection volume, beta 2-microglobulin and alpha 1-microglobulin reduction ratios, and body composition in pre-dilution online haemodiafiltration, NEPHROLOGY, 27(7), 601-609, 202207
  27. A Combination of Iohexol Treatment and Ionizing Radiation Exposure Enhances Kidney Injury in Contrast-Induced Nephropathy by Increasing DNA Damage, RADIATION RESEARCH, 197(4), 384-395, 202204
  28. COVID-19-associated pulmonary aspergillosis in hemodialysis patients, CLINICAL KIDNEY JOURNAL, 15(5), 985-991, 20220429
  29. 15-Deoxy-Delta 12,14-prostaglandin J(2) Inhibits Angiotensin II-induced Fibronectin Expression via Hepatocyte Growth Factor Induction in Human Peritoneal Mesothelial Cells, THERAPEUTIC APHERESIS AND DIALYSIS, 14(1), 43-51, 201002
  30. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta 1 signaling, KIDNEY INTERNATIONAL, 84(2), 297-307, 201308
  31. PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation., Clin Exp Immunol, 144(2), 353-361, 20060501
  32. Factors influencing arteriovenous fistula dysfunction in Japanese patients on chronic hemodialysis, The International Journal of Artificial Organs, 22(1), 14-17, 19990401
  33. ★, Tenascin expression may reflect the activity and chronicity of human IgA nephropathy., 50(4), 205-213, 19981001
  34. Role of tenascin in human immunoglobulin A nephropathy., 25(5), 247-254, 19970901
  35. The influence of steroid therapy in patients with IgA nephropathy., Nephron, 86(6), 197-198, 20001001
  36. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney., Kidney International, 63(4), 1256-1264, 20030401
  37. Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis., Nephrology Dialysis Transplantation, 18(1), 178-181, 20030101
  38. Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies., Journal of the American Society of Nephrology, 15(7), 1835-1843, 20040601
  39. Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis., Clin Exp Nephrol, 20130701
  40. Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(6), 921-929, 201212
  41. Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats, PLOS ONE, 9(4), 20140402
  42. Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(2), 189-193, 201404
  43. Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(3), 499-506, 201406
  44. Telomeric G-Tail Length and Hospitalization for Cardiovascular Events in Hemodialysis Patients, CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(12), 2117-2122, 201412
  45. Successful treatment with plasma exchange for ANCA-negative pauci-immune crescentic glomerulonephritis with D-negative hemolytic uremic syndrome, CLINICAL NEPHROLOGY, 82(4), 268-272, 201410
  46. The Serum Lipids Levels may be Underestimated in Patients on Hemodialysis, INTERNAL MEDICINE, 54(8), 887-894, 2015
  47. Hemodialysis Immediately After Cardiac Catheterization Is a Risk Factor for Intradialytic Hypotension, THERAPEUTIC APHERESIS AND DIALYSIS, 19(3), 245-249, 201506
  48. Expression of age-related factors during the development of renal damage in patients with IgA nephropathy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(5), 830-837, 201510
  49. Vascular access intervention by a nephrologist in Hiroshima, JOURNAL OF VASCULAR ACCESS, 16, S58-S61, 201511
  50. Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model., Nephron Exp Nephrol, 112(2), 59-69, 2009
  51. Effect of AST-120, an oral adsorbrnt, on inhibition of the loss of renal function in CRF patients, NEPHROLOGY DIALYSIS TRANSPLANTATION, 21, 383-383, 2006
  52. Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2, THERAPEUTIC APHERESIS AND DIALYSIS, 11(2), 94-100, 2007
  53. Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction, NEPHROLOGY, 12(6), 565-571, 2007
  54. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury, TRANSPLANTATION, 84(2), 207-213, 2007
  55. Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice., PLoS One., 11(8), e0160993, 20160811
  56. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study., Hemodial Int, 20(4), 580-588, 201610
  57. Linagliptin Ameliorates MethylglyoxalInduced Peritoneal Fibrosis in Mice, PLOS ONE, 11(8), 20160811
  58. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study, HEMODIALYSIS INTERNATIONAL, 20(4), 580-588, 201610
  59. Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study, JOURNAL OF VIRAL HEPATITIS, 23(11), 850-856, 201611
  60. Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20(6), 918-925, 201612
  61. Seasonal variation in hemodialysis initiation: A single-center retrospective analysis, PLOS ONE, 12(5), 20170602
  62. AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations, CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 7(2), 102-107, 2017
  63. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients, THERAPEUTIC APHERESIS AND DIALYSIS, 12(3), 232-236, 2008
  64. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis, NEPHROLOGY DIALYSIS TRANSPLANTATION, 23(11), 3418-3426, 2008
  65. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta, LABORATORY INVESTIGATION, 89(1), 47-58, 2009
  66. Mizoribine Suppresses the Progression of Experimental Peritoneal Fibrosis in a Rat Model, NEPHRON EXPERIMENTAL NEPHROLOGY, 112(2), E59-E69, 2009
  67. C-C Chemokine Receptor 2 Expression by Circulating Monocytes Influences Atherosclerosis in Patients on Chronic Hemodialysis, THERAPEUTIC APHERESIS AND DIALYSIS, 13(3), 205-212, 2009
  68. 15-Deoxy-Delta 12,14-prostaglandin J(2) Inhibits Angiotensin II-induced Fibronectin Expression via Hepatocyte Growth Factor Induction in Human Peritoneal Mesothelial Cells, THERAPEUTIC APHERESIS AND DIALYSIS, 14(1), 43-51, 2010
  69. A SUPER HIGH-FLUX DIALYZER (PS: APS-EA) ELIMINATES 40% OF INJECTED RECOMBINANT HUMAN (RH) ERITHROPOIETIN (EPO) DURING 4-HOUR HEMODIALYSIS (HD), NEPHROLOGY DIALYSIS TRANSPLANTATION, 27, 213-213, 2012
  70. PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) HETERODIMERS REDUCE SERUM LDL-CHOLESTEROL (LDL-C) LEVELS IN MAINTENANCE HEMODIALYSIS (HD) PATIENTS ASSOCIATED WITH DYSLIPIDEMIA CHARACTERIZED BY INCREASED TRIGLYCERIDE-RICH LIPOPROTEINS, NEPHROLOGY DIALYSIS TRANSPLANTATION, 27, 215-216, 2012
  71. Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(6), 921-929, 2012
  72. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta 1 signaling, KIDNEY INTERNATIONAL, 84(2), 297-307, 2013
  73. Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats, PLOS ONE, 9(4), 2014
  74. Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(2), 189-193, 2014
  75. Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(3), 499-506, 2014
  76. Telomeric G-Tail Length and Hospitalization for Cardiovascular Events in Hemodialysis Patients, CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(12), 2117-2122, 2014
  77. Successful treatment with plasma exchange for ANCA-negative pauci-immune crescentic glomerulonephritis with D-negative hemolytic uremic syndrome, CLINICAL NEPHROLOGY, 82(4), 268-272, 2014
  78. The Serum Lipids Levels may be Underestimated in Patients on Hemodialysis, INTERNAL MEDICINE, 54(8), 887-894, 2015
  79. Hemodialysis Immediately After Cardiac Catheterization Is a Risk Factor for Intradialytic Hypotension, THERAPEUTIC APHERESIS AND DIALYSIS, 19(3), 245-249, 2015
  80. Efficacy of add-on therapy of aliskiren to an angiotensin II receptor blocker on renal outcomes in advanced-stage chronic kidney disease: a prospective, randomized, open-label study, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(4), 631-638, 2015
  81. Expression of age-related factors during the development of renal damage in patients with IgA nephropathy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(5), 830-837, 2015
  82. Vascular access intervention by a nephrologist in Hiroshima, JOURNAL OF VASCULAR ACCESS, 16, S58-S61, 2015
  83. Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 27(1), 203-215, 2016
  84. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression, KIDNEY INTERNATIONAL, 89(1), 147-157, 2016
  85. High glucose promotes TGF-beta 1 production by inducing FOS expression in human peritoneal mesothelial cells, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20(1), 30-38, 2016
  86. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis., Clin Exp Nephrol, 2017
  87. Valproic acid attenuates renal fibrosis through the induction of autophagy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 21(5), 771-780, 201710
  88. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients, NEPHROLOGY, 22(12), 947-953, 201712
  89. Diffuse large B-cell lymphoma presenting as bilateral renal infiltration leading to acute kidney injury, CEN CASE REPORTS, 6(2), 140-147, 201711
  90. Protective Effects of Japanese Soybean Paste (Miso) on Stroke in Stroke-Prone Spontaneously Hypertensive Rats (SHRSP), AMERICAN JOURNAL OF HYPERTENSION, 31(1), 43-47, 201801
  91. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(1), 78-84, 201802
  92. Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS, 22(1), 31-39, 201802
  93. A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-alpha and TGF-beta(1) pathways, SCIENTIFIC REPORTS, 7, 20170515
  94. N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patients, INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 41(3), 135-143, 201803
  95. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report, BMC NEPHROLOGY, 19, 20180503
  96. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, PLOS ONE, 13(5), 20180503
  97. A case of immunotactoid glomerulopathy with false-negative IgG staining, BMC NEPHROLOGY, 19, 20180615
  98. High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(4), 835-842, 201808
  99. Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II, CELL DEATH & DISEASE, 9(808), 20180724
  100. Klotho as a Therapeutic Target during the Development of Renal Fibrosis, SCIENTIFIC ASPECTS OF DIALYSIS THERAPY: JSDT/ISBP ANNIVERSARY EDITION, 189, 178-183, 2017
  101. Na+-Cl- cotransporter-mediated chloride uptake contributes to hypertension and renal damage in aldosterone-infused rats, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 315(2), 300-312, 2018
  102. Dec1 and CLOCK Regulate Na+/K+-ATPase 1 Subunit Expression and Blood Pressure, HYPERTENSION, 72(3), 746-754, 201809
  103. A Case of Fibronectin Glomerulopathy Caused by Missense Mutations in the Fibronectin 1 Gene, kidney Int Rep, 2(5), 969-972, 2017
  104. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients, Nephrology (Carlton), 23(9), 837-845, 2018
  105. AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations., Case Rep Nephrol Dial, 7, 102-107, 2017
  106. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients, NEPHROLOGY, 23(9), 837-845, 201809
  107. Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction, PLOS ONE, 13(8), 20180816
  108. Comparing the 12-month patency of low- versus high-pressure dilation in failing arteriovenous fistulae: A prospective multicenter trial (YOROI study), JOURNAL OF VASCULAR ACCESS, 19(5), 477-483, 201809
  109. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(5), 1167-1173, 201810
  110. TGF-beta 1 promotes expression of fibrosis-related genes through the induction of histone variant H3.3 and histone chaperone HIRA, SCIENTIFIC REPORTS, 8, 20180919
  111. Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis, STEM CELLS TRANSLATIONAL MEDICINE, 7(12), 893-905, 201812
  112. NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells, JOURNAL OF BIOLOGICAL CHEMISTRY, 294(1), 101-115, 20190104
  113. The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 19(12), 201812
  114. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report, CLINICAL NEPHROLOGY, 90(3), 232-236, 201809
  115. Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan, JOURNAL OF ARTIFICIAL ORGANS, 22(2), 146-153, 201906
  116. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis, PLOS ONE, 12(3), 20170309
  117. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients, INTERNATIONAL UROLOGY AND NEPHROLOGY, 51(6), 1043-1052, 201906
  118. Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(1), 217-223, 20190618
  119. Renal medullary tonicity regulates RNF183 expression in the collecting ducts via NFAT5, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(2), 436-442, 20190625
  120. microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress, PLOS ONE, 14(6), 20190614
  121. Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice, DIABETOLOGY & METABOLIC SYNDROME, 11, 20190722
  122. Novel Asp511Thr mutation in McArdle disease with acute kidney injury caused by rhabdomyolysis, CEN CASE REPORTS, 8(3), 194-199, 201908
  123. High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate >= 60 mL/min/1.73 m(2): A cross-sectional study, PLOS ONE, 14(8), 20190801
  124. Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients, RENAL FAILURE, 41(1), 770-777, 20190101
  125. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16(INK4a), KIDNEY INTERNATIONAL, 96(5), 1162-1175, 201911
  126. Vascular access management after percutaneous transluminal angioplasty using a calcium alginate sheet: a randomized controlled trial, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(9), 1592-1596, 201909
  127. Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(19), 201910
  128. Iliopsoas Abscess in Hemodialysis Patients With End-Stage Kidney Disease, THERAPEUTIC APHERESIS AND DIALYSIS, 23(6), 534-541, 201912
  129. Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma, CEN CASE REPORTS, 9(1), 48-54, 202002
  130. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli, CEN CASE REPORTS, 8(4), 266-270, 201911
  131. NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells., J Biol Chem, 294(1), 101-115, 2019/1/4
  132. Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan, JOURNAL OF ARTIFICIAL ORGANS, 22(2), 146-153, 2019
  133. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study, HEMODIALYSIS INTERNATIONAL, 20(4), 580-588, 2016
  134. Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20(6), 918-925, 2016
  135. Seasonal variation in hemodialysis initiation: A single-center retrospective analysis, PLOS ONE, 12(6), 2017
  136. A Case of Fibronectin Glomerulopathy Caused by Missense Mutations in the Fibronectin 1 Gene, KIDNEY INTERNATIONAL REPORTS, 2(5), 969-972, 2017
  137. Protective Effects of Japanese Soybean Paste (Miso) on Stroke in Stroke-Prone Spontaneously Hypertensive Rats (SHRSP), AMERICAN JOURNAL OF HYPERTENSION, 31(1), 43-47, 2018
  138. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(1), 78-84, 2018
  139. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (vol 22, pg 78, 2018), CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(1), 85-86, 2018
  140. A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-alpha and TGF-beta(1) pathways, SCIENTIFIC REPORTS, 7, 2017
  141. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report, BMC NEPHROLOGY, 19, 2018
  142. A case of immunotactoid glomerulopathy with false-negative IgG staining, BMC NEPHROLOGY, 19, 2018
  143. A consensus statement on health-care transition of patients with childhood-onset chronic kidney diseases: providing adequate medical care in adolescence and young adulthood, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(4), 743-751, 2018
  144. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report, CLINICAL NEPHROLOGY, 90(3), 232-236, 2018
  145. Comparing the 12-month patency of low- versus high-pressure dilation in failing arteriovenous fistulae: A prospective multicenter trial (YOROI study), JOURNAL OF VASCULAR ACCESS, 19(5), 477-483, 2018
  146. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(5), 1167-1173, 2018
  147. TGF-beta 1 promotes expression of fibrosis-related genes through the induction of histone variant H3.3 and histone chaperone HIRA, SCIENTIFIC REPORTS, 8, 2018
  148. Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis, STEM CELLS TRANSLATIONAL MEDICINE, 7(12), 893-905, 2018
  149. The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 19(12), 2018
  150. Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(1), 217-223, 2019
  151. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients, INTERNATIONAL UROLOGY AND NEPHROLOGY, 51(6), 1043-1052, 2019
  152. Renal medullary tonicity regulates RNF183 expression in the collecting ducts via NFAT5, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(2), 436-442, 2019
  153. microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress, PLOS ONE, 14(6), 2019
  154. Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice, DIABETOLOGY & METABOLIC SYNDROME, 11, 2019
  155. High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate >= 60 mL/min/1.73 m(2): A cross-sectional study, PLOS ONE, 14(8), 2019
  156. Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients, RENAL FAILURE, 41(1), 770-777, 2019
  157. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16(INK4a), KIDNEY INTERNATIONAL, 96(5), 1162-1175, 2019
  158. Vascular access management after percutaneous transluminal angioplasty using a calcium alginate sheet: a randomized controlled trial, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(9), 1592-1596, 2019
  159. Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(19), 2019
  160. ELEVATION OF SERUM BISPHENOL S (BPS) CONCENTRATIONS IN PATIENTS UNDERGOING HEMODIAYLSIS (HD) BY CHANGING DIALYZERS FROM POLYSULFONE TO POLYETHERSULFONE MEMBRANES, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 227-227, 2019
  161. THE IMPACT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) ON SERUM LIPID PROFILE IN HEMODIALYSIS (HD) PATIENTS, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 293-293, 2019
  162. DOCOSAHEXAENOIC ACID ADMINISTRATION INCREASES EGFR THROUGH UPREGULATION OF NNOS EXPRESSION, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 2019
  163. LDL-CHOLESTEROL LEVEL IS ASSOCIATED WITH DOWNREGULATION OF KLOTHO EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 471-471, 2019
  164. WEEKLY AND MONTHLY ERYTHROPOIESIS STIMULATING AGENTS ARE REMOVED DURING HEMODIALYSIS SESSION, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 521-521, 2019
  165. Iliopsoas Abscess in Hemodialysis Patients With End-Stage Kidney Disease, THERAPEUTIC APHERESIS AND DIALYSIS, 23(6), 534-541, 2019
  166. Relationship of serum magnesium level with body composition and survival in hemodialysis patients, HEMODIALYSIS INTERNATIONAL, 24(1), 99-107, 2020
  167. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 24(5), 435-443, 2020
  168. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats, STEM CELL RESEARCH & THERAPY, 11(1), 130-130, 2020
  169. NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells, JOURNAL OF BIOLOGICAL CHEMISTRY, 294(1), 101-115, 2019
  170. TELOMERIC G-TAIL LENGTH AS A GOOD PREDICTOR OF CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS, NEPHROLOGY, 19, 116-117, 2014
  171. A classic variant of Fabry disease in a family with the M296I late-onset variant, CEN CASE REPORTS, 10(1), 106-110, 202102
  172. Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 25(2), 110-119, 202102
  173. Iron, coronary artery calcification, and mortality in patients undergoing hemodialysis, RENAL FAILURE, 43(1), 371-380, 20210101
  174. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis, STEM CELL RESEARCH & THERAPY, 12(1), 20210323
  175. Interferon-gamma enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis, SCIENTIFIC REPORTS, 11(1), 20210113
  176. Linagliptin Ameliorates MethylglyoxalInduced Peritoneal Fibrosis in Mice, PLOS ONE, 11(8), 2016
  177. Chronic kidney disease caused by maternally inherited diabetes and deafness: a case report, CEN CASE REPORTS, 10(2), 220-225, 202105
  178. Association and predictive value of geriatric nutritional risk index, body composition, or bone mineral density in haemodialysis patients, NEPHROLOGY, 26(4), 341-349, 202104
  179. Localization and Maintenance of Engrafted Mesenchymal Stem Cells Administered via Renal Artery in Kidneys with Ischemia-Reperfusion Injury, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(8), 202104
  180. Low-Vacuum Scanning Electron Microscopy to Assess Histopathological Resolution of Class V Lupus Nephritis: A Case Report, CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 11(1), 36-47, 2021
  181. Effectiveness of a treatment algorithm for hemodialysis-associated pruritus in terms of changes in medications, RENAL REPLACEMENT THERAPY, 7(1), 20210526
  182. Valproic acid attenuates renal fibrosis through the induction of autophagy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 21(5), 771-780, 2017
  183. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients, NEPHROLOGY, 22(12), 947-953, 2017
  184. Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS, 22(1), 31-39, 2018
  185. N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patients, INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 41(3), 135-143, 2018
  186. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, PLOS ONE, 13(5), 2018
  187. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis, PLOS ONE, 12(3), 2017
  188. High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(4), 835-842, 2018
  189. Klotho as a Therapeutic Target during the Development of Renal Fibrosis, SCIENTIFIC ASPECTS OF DIALYSIS THERAPY, 189, 178-183, 2017
  190. Dec1 and CLOCK Regulate Na+/K+-ATPase 1 Subunit Expression and Blood Pressure, HYPERTENSION, 72(3), 746-754, 2018
  191. Na+-Cl- cotransporter-mediated chloride uptake contributes to hypertension and renal damage in aldosterone-infused rats, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 315(2), F300-F312, 2018
  192. Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction, PLOS ONE, 13(8), 2018
  193. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients, NEPHROLOGY, 23(9), 837-845, 2018
  194. Eighteen-year follow-up cohort study on hepatitis B and C virus infections related long-term prognosis among hemodialysis patients in Hiroshima, Journal of Medical Virology, 20200624
  195. Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy, Intestinal Research, 202009
  196. A case report of adult-onset COQ8B nephropathy presenting focal segmental glomerulosclerosis with granular swollen podocytes, BMC Nephrology, 21(1), 376-376, 202008
  197. Different risk factors are associated with vascular access patency after construction and percutaneous transluminal angioplasty in patients starting hemodialysis, The Journal of Vascular Access, 22(5), 707-715, 202109
  198. Serum-free medium and hypoxic preconditioning synergistically enhance the therapeutic effects of mesenchymal stem cells on experimental renal fibrosis, STEM CELL RESEARCH & THERAPY, 12(1), 20210823
  199. Lower Geriatric Nutritional Risk Index (GNRI) Is Associated with Higher Risk of Fractures in Patients Undergoing Hemodialysis, NUTRIENTS, 13(8), 202108
  200. N-terminal pro brain natriuretic peptide predicts both all-cause and cardiovascular disease mortality in Japanese hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 25(10), 1142-1150, 202110
  201. The histopathological spectrum of kidney biopsies in patients with thymoma and myasthenia gravis: a report of 24 biopsies from a single institution, CLINICAL KIDNEY JOURNAL, 14(9), 2090-2100, 202109
  202. Klotho overexpression protects against renal aging along with suppression of transforming growth factor-beta 1 signaling pathways, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 321(6), F799-F811, 202112
  203. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys, PLOS ONE, 16(10), 2021

Invited Lecture, Oral Presentation, Poster Presentation

  1. PPARalpha Modulator Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis, Shinkai Y ,Tamura R, Ishiuchi N, Osaki Y, Maeoka Y, Sasaki K, Masaki T, American Society of Nephrology 2023, 2023/11/04, Without Invitation, English
  2. Etelcalcetide Use Affects Changes in Agatston Coronary Artery Calcium (CAC) Score in Maintenance Dialysis Patients, Doi Toshiki,Morii Kenichi,Mizuiri Sonoo,Nishizawa Yoshiko,Masaki Takao, American Society of Nephrology 2023, 2023/11/04, Without Invitation, English
  3. Comparison of Therapeutic Effects of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells on Renal Fibrosis, Yoshida Maria,Nakashima Ayumu,Ishiuchi Naoki,Miyasako Kisho,Tanaka Yoshiki,Morimoto Keisuke,Sasaki Kensuke,Masaki Takao, American Society of Nephrology 2023, 2023/11/04, Without Invitation, English
  4. The Effects of Regulatory T Cell Induction by Mesenchymal Stem Cells Pretreated with Interferon-Gamma on Renal Inflammation and Fibrosis, Kurawaki So,Nakashima Ayumu,Ishiuchi Naoki,Kanai Ryo,Sasaki Kensuke,Masaki Takao, American Society of Nephrology 2023, 2023/11/04, Without Invitation, English
  5. Magnesium Protects Against CKD Progression by Reducing DNA Damage, Matsubara M, Sasaki K, Ishiuchi N, Takahashi A, Osaki Y, Maeoka Y, Masaki T, American Society of Nephrology 2023, 2023/11/03, Without Invitation, English
  6. Red Blood Cell Distribution Width-Coefficient of Variation as an Indicator of the Requirement for and Efficacy of Daprodustat in Hemodialysis Patients Switching from Erythropoietin-Stimulating Agents, Morii Kenichi, Doi Toshiki, Nishizawa Yoshiko, Yamashita Kazuomi, Shigemoto enichiro, Mizuiri Sonoo, Masaki Takao, American Society of Nephrology 2023, 2023/11/02, Without Invitation, English
  7. Coronary Artery Calcification Is Associated with Low Kt/Vurea and Extracellular Fluid Excess in Patients on Hemodialysis, Mizuiri Sonoo, Nishizawa Yoshiko, Doi Toshiki,Okubo Aiko, Morii Kenichi, Yamashita Kazuomi, Karasuda Kazuyoshi, Usui Koji, Shigemoto Kenichiro, Masaki Takao, American Society of Nephrology 2023, 2023/11/02, Without Invitation, English
  8. Absolute Iron Deficiency, Coronary Artery Calcification, and Mortality in Dialysis Patients, Mizuiri Sonoo,Nishizawa Yoshiko, Doi Toshiki, Okubo Aiko, Morii Kenichi, Yamashita Kazuomi, Usui Koji, Shigemoto Kenichiro, Masaki Takao, American Society of Nephrology 2023, 2023/11/02, Without Invitation, English
  9. Rapidly Increased Pattern of Erythropoiesis⁻Stimulating Agent (ESA) Resistance Is a Predictor of Poor Renal Prognosis in Predialysis CKD Patients: BRIGHTEN Study Subanalysis, Kawamoto Shinya, Masaki Takao, Maruyama Shoichi, Yamakawa Akane, Kagimura Tatsuo, Narita Ichiei, American Society of Nephrology 2023, 2023/11/02, Without Invitation, English
  10. Epidemiology of Medical Kidney Disease in the Southwestern United States, 1989-2018, Takahashi A, Miyauchi T, Kevin Ren KYM, Doi T, Masaki T, Yamashita M, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  11. Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients, Ookubo A, Doi T, Nishizawa Y, Shigemoto K, Mizuiri S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  12. The Effect of Predilution Online Hemodiafiltration on Body Composition, Nutritional Status, and Mortality, Mizuiri S, Nishizawa Y, Okubo A, Doi T, Yamashita K, Shigemoto K, Usui K, Michiko Arita, Naito T, Doi S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  13. Coronary Artery Calcification Is a Risk Factor for Intradialytic Hypotension in Hemodialysis Patients, Mizuiri S, Nishizawa Y, Doi T, Yamashita K, Shigemoto K, Usui K, Arita M, Naito T, Doi S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  14. Identification of Factors Affecting Changes in the Agatston Coronary Artery Calcification Score in Maintenance Hemodialysis Patients, Morii K, Doi T, Nishizawa Y, Shigemoto K, Mizuiri S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  15. Inhibition of H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, Ryo Tamura, Shigehiro Doi, Toshinori Ueno, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  16. TGF-b1 promotes fibrotic gene expression through induction of histone variant H3.3 and histone chaperone HIRA, Toshihiro Shindo, Shigehiro Doi, Kensuke Sasaki, Ayumu Nakashima, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  17. MicroRNA-200c is involved in Klotho reduction by oxidative stress in human tubular cells, Kenichi Morii, Satoshi Yamasaki, Shigehiro Doi, Kensuke Sasaki, Toshinori Ueno, Ayumu Nakashima, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  18. Prognostic Factors in sepsis patients who have undergone direct hemoperfusion with polymyxin b-immobilized fibers, Aiko Okubo, Ayumu Nakashima, Shigehiro Doi, Toshihiro Ueno, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  19. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental renal fibrosis by their strong immunosuppressive effects, Ken Yoshida, Ayumu Nakashima, Shigehiro Doi, Toshinori Ueno, Yukio Kato, Yukihito Higashi, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  20. Inhibition of H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, Ryo Tamura, Shigehiro Doi, Toshinori Ueno, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  21. TGF-b1 promotes fibrotic gene expression through induction of histone variant H3.3 and histone chaperone HIRA, Toshihiro Shindo, Shigehiro Doi, Kensuke Sasaki, Ayumu Nakashima, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  22. MicroRNA-200c is involved in Klotho reduction by oxidative stress in human tubular cells, Kenichi Morii, Satoshi Yamasaki, Shigehiro Doi, Kensuke Sasaki, Toshinori Ueno, Ayumu Nakashima, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, Japanese
  23. Prognostic Factors in sepsis patients who have undergone direct hemoperfusion with polymyxin b-immobilized fibers, Aiko Okubo, Ayumu Nakashima, Shigehiro Doi, Toshihiro Ueno, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  24. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental renal fibrosis by their strong immunosuppressive effects, Ken Yoshida, Ayumu Nakashima, Shigehiro Doi, Toshinori Ueno, Yukio Kato, Yukihito Higashi, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  25. Inhibitory Effect the Chromatin Histone H3-Lysine 4 Methyltransferase(SET7/9)on the Tubulointerstitial Fibrosis, Kensuke Sasaki, Ayumu Nakashima, Shigehiro Doi, Takao Masaki, American Society of Nephrology 2014, 2014/11/11, Without Invitation, English
  26. Mizoribine Suppressed Pyroptosis and Ameliorated Renal Inflammation in Aldosterone-Salt Treated Rats, Toshiki Doi, Shigehiro Doi, Ayumu Nakashima, Takao Masaki, American Society of Nephrology 2013, 2013/11/06, Without Invitation, English
  27. High Glucose Promotes TGF-β1 Productiono by Inducing FOS Expression in Human Peritoneal Mesothelial Cells, Shigehiro Doi, Keiko Kokoroishi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology 2013, 2013/11/06, Without Invitation, English
  28. Serum Lipids Levels may be Underestimated in Patients on Hemodialysis, Toshinori Ueno, Shigehiro Doi, Toru Kawai, Takao Masaki, WCN 2014 Satellite Symposium Kidney and Lipids, 2013/06/06, Without Invitation, English, fukuoka
  29. Comparison of Survival rate between Hemodialysis and Peritoneal dialysis patients: A prospective cohort study with Propensity score matching, Mami Miyazaki, Shigehiro Doi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  30. Klotho Deficiency Intensifies Hypoxia-Induced Expression of INF-a/b Through Upregulation of Rig-I, Asako Urabe, Shigehiro Doi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  31. A Combination of Contrast Media and Radiation Increases DNA Damage and Delays DNA Damage Repair in Mouse Kidneys, Shu Fujino, Shigehiro Doi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  32. Combined Value of Geriatric Nutritional Risk Index, Body Composition, and Bone Mineral Density for Predicting Mortality of Hemodialysis Patients, Sonoo Mizuiri, Nishizawa Yoshiko, Kazuomi Yamashita, Shigehiro Doi, Shigemoto Kennichiro, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  33. Association Among Iron, Coronary Artery Calcification, and Mortality in Hemodialysis Patients, Sonoo Mizuiri, Nishizawa Yoshiko, Kazuomi Yamashita, Usui Kohji, Shigehiro Doi, Shigemoto Kennichiro, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  34. Inhibition of Mineralocorticoid Receptor Ameliorates Salt-Sensitive Hypertension After Ischemic-Reperfusion Injury in Rats, Takumi Matsumoto, Shigehiro Doi, Ayumu Nakashima, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English

External Funds

Acceptance Results of Competitive Funds

  1. KAKENHI, 2014, 2016
  2. KAKENHI, 2013, 2015
  3. KANENHI, 2016, 2018
  4. KAKENHI, 2017, 2020
  5. KAKEN, 2016, 2018
  6. KAKENHI(Grant-in-Aid for Scientific Research (C)), 2017, 2019
  7. KAKENHI, 2019, 2022
  8. KAKENHI, 2016, 2018

Social Activities

Organizing Academic Conferences, etc.

  1. The 32th Annual Meeting of the Chugoku Society for Renal Failure, 2022/12, 2022/12
  2. The 27th Annual Meeting of Japanese Society for Hemodiafiltration, 2021/10, 2021/10